Oral Superoxide Dismutase (GLISODin) to Decrease Melasma Severity.
NCT03878433
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Melasma
Interventions
DRUG:
Glisodin
OTHER:
placebo
Sponsor
Centre Hospitalier Universitaire de Nice